TCG IV Gp, LLC, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 298,392 shares at $13.20 ($4.0M) on 2022-05-18, disclosed to the SEC on 2022-05-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.42 | 2,939 | $39K | 1.0% |
| 2 | $13.42 | 86,110 | $1.2M | 29.1% |
| 3 | $13.42 | 86,110 | $1.2M | 29.1% |
| 4 | $13.20 | 2,067 | $27K | 0.7% |
| 5 | $13.20 | 60,583 | $800K | 20.1% |
| 6 | $13.20 | 60,583 |
| $800K |
| 20.1% |
| Total | $13.33 avg | 298,392 | $4.0M | 100% |